Skip to main content
Clinical Trials/ChiCTR-ICR-15007169
ChiCTR-ICR-15007169Not yet recruiting治疗新技术临床试验

压力感应导管对比普通导管针对阵发性房颤消融治疗有效性和安全性的随机对照研究

自筹1 site in 1 country220 target enrollmentStarted: January 1, 2016Last updated:

Trial Snapshot

Phase
治疗新技术临床试验
Status
Not yet recruiting
Sponsor
Enrollment
220
Locations
1
Primary Endpoint
房颤复发

Study Overview

Brief Summary

评价压力感应导管对比普通导管针对阵发性房颤消融治疗有效性和安全性

Study Design

Study Type
干预性研究
Primary Purpose
随机平行对照

Eligibility Criteria

Ages
18 to 75 (—)
Sex
All

Inclusion Criteria

  • 对抗心律失常药物不耐受;

Exclusion Criteria

  • 有冠心病病史,曾接受支架植入治疗;

Arms & Interventions

压力感应导管组

使用压力感应导管

普通导管组

使用普通导管

Outcomes

Primary Outcomes

房颤复发

Secondary Outcomes

  • 肺静脉重联
  • 并发症
  • 消融手术相关指标

Investigators

Sponsor
自筹

Study Sites (1)

Loading locations...

Similar Trials